Clayton Russell (CIK 1530072) reported 2 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-01-27). Recent activity: Buy LRMR (25,637 shares), Buy LRMR (23,306 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-01-27 | Larimar Therapeutics, Inc. (LRMR) | Chief Medical Officer | Buy | 25,637 | $0 |
| 2025-01-24 | Larimar Therapeutics, Inc. (LRMR) | Chief Medical Officer | Buy | 23,306 | $0 |
Source: SEC Form 4 filings · as of 2026-01-27